Clinical Study Of Schizophrenia in Both Men and Women

Completed · Phase 3

Conditions studied: Schizophrenia

In brief

The objective of this study is to evaluate the effectiveness of a marketed drug in the treatment of schizophrenia, as an add-on therapy to antipsychotics over a 12-week period. Subjects with schizophrenia who have been maintained on a stable dose of antipsychotics and who fulfill the screening entrance criteria will have an assessment 1-7 days after the first visit to confirm eligibility.

Key facts

Study ID

NCT00071747

Run by

GlaxoSmithKline

People needed

176

Starts

2003-08-01

Expected to finish

2005-01-01

Last updated by the study team

2016-09-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• If female, must not be pregnant, or must be incapable of conceiving or be taking steps to prevent conception.
• Diagnosis of Schizophrenia
• Patients must be taking clozapine monotherapy or other atypical antipsychotic at least 3 months prior to this study.

You may not qualify if…

• Patients who are currently taking or have taken antidepressant medication in the last month prior.
• Patients who are or have been suicidal or homicidal in the last 6 months.
• Patients with a history of autistic disorder or another pervasive developmental disorder
• Patients whose condition is due to the direct physiological effects of a substance (e.g. a drug of abuse, a medication) or a general medical condition

Where it is running

• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Garden Grove, California, United States
• GSK Investigational Site — La Mesa, California, United States
• GSK Investigational Site — National City, California, United States
• GSK Investigational Site — Oceanside, California, United States
• GSK Investigational Site — Rosemead, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Hartford, Connecticut, United States
• GSK Investigational Site — Maitland, Florida, United States
• GSK Investigational Site — North Miami, Florida, United States
• GSK Investigational Site — Granite City, Illinois, United States
• GSK Investigational Site — Glen Burnie, Maryland, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Reno, Nevada, United States
• GSK Investigational Site — Clementon, New Jersey, United States
• GSK Investigational Site — Kenilworth, New Jersey, United States
• GSK Investigational Site — Orangeburg, New York, United States
• GSK Investigational Site — Rochester, New York, United States
• GSK Investigational Site — Butner, North Carolina, United States
• GSK Investigational Site — Charlotte, North Carolina, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Beachwood, Ohio, United States
• GSK Investigational Site — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.